King Assures Investors Embeda Marketing Materials Not Lost In DDMAC "Black Hole"
Five months after the launch of King's oral morphine Embeda, execs still await FDA approval of marketing materials.
Five months after the launch of King's oral morphine Embeda, execs still await FDA approval of marketing materials.